Wessels H - Search Results

1

Origin of T-lymphocytes in human mixed hematopoietic colonies.

van der Maazen R, de Witte T, Preijers F, Janssen J, Blankenborg G, Wessels H. van der Maazen R, et al. Among authors: wessels h. Exp Hematol. 1987 Nov;15(10):1080-5. Exp Hematol. 1987. PMID: 3311786

2

Detection of incorporated iododeoxyuridine in colonies by immunoperoxidase staining: a novel method to measure the proportion of cycling colony-forming cells.

Van der Lely N, Minderman H, Wessels H, Hillegers M, Linssen P, Pennings A, Brons P, Boezeman J, De Witte T. Van der Lely N, et al. Among authors: wessels h. Exp Hematol. 1995 Mar;23(3):236-43. Exp Hematol. 1995. PMID: 7875241

3

A new multichamber counterflow centrifugation rotor with high-separation capacity and versatile potentials.

Plas A, de Witte T, Wessels H, Haanen C. Plas A, et al. Among authors: wessels h. Exp Hematol. 1988 Jun;16(5):355-9. Exp Hematol. 1988. PMID: 3286279

4

Cytotoxicity of CD3-ricin A chain immunotoxins in relation to cellular uptake and degradation kinetics.

van Oosterhout YV, Preijers FW, Wessels HM, de Witte T. van Oosterhout YV, et al. Among authors: wessels hm. Cancer Res. 1992 Nov 1;52(21):5921-5. Cancer Res. 1992. PMID: 1394218

5

In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells.

Speth PA, Raijmakers RA, Boezeman JB, Linssen PC, de Witte TJ, Wessels HM, Haanen C. Speth PA, et al. Among authors: wessels hm. Eur J Cancer Clin Oncol. 1988 Apr;24(4):667-74. doi: 10.1016/0277-5379(88)90297-0. Eur J Cancer Clin Oncol. 1988. PMID: 3383969

6

Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins.

van Oosterhout YV, van den Herik-Oudijk IE, Wessels HM, de Witte T, van de Winkel JG, Preijers FW. van Oosterhout YV, et al. Among authors: wessels hm. Cancer Res. 1994 Jul 1;54(13):3527-32. Cancer Res. 1994. PMID: 7516821

7

Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics.

Brons PP, Haanen C, Boezeman JB, Muus P, Holdrinet RS, Pennings AH, Wessels HM, de Witte T. Brons PP, et al. Among authors: wessels hm. Ann Hematol. 1993 May;66(5):225-33. doi: 10.1007/BF01738470. Ann Hematol. 1993. PMID: 8507717

8

Plasma and cellular pharmacokinetics of m-AMSA related to in vitro toxicity towards normal and leukemic clonogenic bone marrow cells (CFU-GM, CFU-L).

Linssen P, Brons P, Knops G, Wessels H, de Witte T. Linssen P, et al. Among authors: wessels h. Eur J Haematol. 1993 Mar;50(3):149-54. doi: 10.1111/j.1600-0609.1993.tb00083.x. Eur J Haematol. 1993. PMID: 8472810

9

Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance.

Smeets ME, Raymakers RA, Vierwinden G, Pennings AH, Wessels H, de Witte T. Smeets ME, et al. Among authors: wessels h. Blood. 1999 Oct 1;94(7):2414-23. Blood. 1999. PMID: 10498614 Free article.

10

A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicity.

Smeets M, Raymakers R, Vierwinden G, Pennings A, van de Locht L, Wessels H, Boezeman J, de Witte T. Smeets M, et al. Among authors: wessels h. Br J Haematol. 1997 Feb;96(2):346-55. doi: 10.1046/j.1365-2141.1997.d01-2024.x. Br J Haematol. 1997. PMID: 9029024 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters